-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer's Disease

Dow Jones·11/12/2025 12:00:00

Please log in to view news